NovaBay gets patents in Australia, NZ, Japan for Aganocide compounds
Australia | Regulatory | By BioSpectrum Bureau | 2 Comment | 01 Jun, 2012
Singapore: NovaBay Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class non-antibiotic, ant...Read more
Medigene, SynCore expand deal for Veregen
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013
Singapore: Germany-headquartered Medigene and SynCore Biotechnology, a member of Sinphar Pharmaceutical Group, have expa...Read more
Kane Biotech issued patent in Australia for Aledex
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Singapore: Canada-based Kane Biotech, which is engaged in the development and commercialization of products that prevent...Read more
Aus, NZ progress on joint regulatory agency
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012
Singapore: Ministers from Australia and New Zealand attended the second meeting of the Australia New Zealand Therapeutic...Read more
Aerocrine receives Australian TGA approval
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 May, 2012
Singapore: Aerocrine received marketing approval for its airway inflammation monitor, NIOX MINO and NIOX MINO Test Kit, ...Read more
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market fol...Read more
Innova, TGR to co-market ELISA technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Jan, 2014
Singapore: Australia-based, TGR BioSciences, a life sciences company focused on the development of rapid, high sensitivi...Read more
Alchemia appoints new chairman
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2014
Singapore: Alchemia, Australia based drug discovery and development company, has appointed Mr. Santo J. Costa as non-exe...Read more
Bionomics, Merck Serono end agreement
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Jun, 2012
Singapore: Australian company Bionomics and Merck Serono, a division of Merck, Darmstadt Germany, have mutually ended t...Read more
AstraZeneca, Alchemia sign $240 mn drug deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the...Read more
Victoria court approves Biota's merger with Nabi Biopharma
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012
Singapore: The Supreme Court of Victoria has approved the scheme of arrangement between Biota Holdings and the holders o...Read more
Eisai gets approval for Halaven in Australia
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2012
Singapore: Eisai Australia, a subsidiary of the Japanese firm Eisai, has received approval from the Australian Departme...Read more
GI Dynamics starts US trial of EndoBarrier
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013
Singapore: GI Dynamics has initiated its US multicenter pivotal clinical trial of EndoBarrier, the Endo trial, for the ...Read more
Pharmaxis for Prix Galien UK award
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014
Singapore: Six companies have been short listed for this year's internationally recognised Prix Galien award UK Orphan D...Read more
Genome of extinct frog revived for fresh egg
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2013
Singapore: The genome of an extinct Australian frog has been revived and reactivated by a team of scientists using sophi...Read more
Protagonist, Ironwood expand peptide R&D deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2012
Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collab...Read more
Luminex restructures, shuts down Australian office
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Singapore: Luminex entered a restructuring plan focused on its assay and related products (ARP) segment's newborn screen...Read more
Lonza produces Bionomics' stem cell cancer drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Apr, 2013
Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate followi...Read more